Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Host Medical Devices & Diagnostics Review Johnson & Johnson (NYSE: JNJ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern...

Key Takeaway: NEW BRUNSWICK, N.J. , Oct. 25, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern Time) on Thursday, November 1 st at the Hyatt Regency Hotel in New Brunswick,

Full Press Release Details

NEW BRUNSWICK, N.J. , Oct. 25, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern Time) on Thursday, November 1 st at the Hyatt Regency Hotel in New Brunswick, N.J.
The program will include presentations by Johnson & Johnson's senior management representing our Medical Devices & Diagnostics segments. Dominic Caruso , Vice President, Finance and Chief Financial Officer will open the meeting.
A live webcast will be available through www.investor.jnj.com . This webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads. A replay and podcast will be available approximately two hours after the meeting concludes.
SOURCE Johnson & Johnson

21 %

Last updated: Oct 25, 2012